Jemperli J Code: J9272

Drug & Product Overview

HCPCS Descriptor Injection, dostarlimab-gxly, 10 mg

HCPCS Added Date January 1, 2022

Manufacturer GlaxoSmithKline

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection

About Jemperli

Jemperli is a medication aligned to the HCPCS J Code: J9272 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by GlaxoSmithKline.

According to CMS Drug Use Information: Dostarlimab is used to treat cancer of the uterus lining (endometrial cancer). This medication is also used to treat certain types of tumor (solid tumors). It works by changing the action of your own immune system, directing it to attack cancer/tumor cells. Dostarlimab belongs to a class of drugs known as monoclonal antibodies.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
00173-0898-03	Jemperli	GlaxoSmithKline LLC	50	500 MG / 10 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Jemperli Pricing & Reimbursement

J9272 Private Payer Reimbursement

$255.70 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

Jemperli Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 8.66%

Avg. Days to File 8.6days

Avg. Days to Pay 24.7days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9272 claims analytics on FocalPoint →

Jemperli CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Jemperli (J9272) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

Jemperli Medically Unlikely Edits (MUE)

The most billing units of J9272 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 10 mg.

Practitioner Office & Hospital Outpatient

100 units / day

= 1,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

Jemperli Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Endometrial Cancer Mismatch Repair Deficient Recurrent or Advanced Solid Tumors

Drug Class

Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Frequently Asked Questions

Is there an available Jemperli billing and coding guide?

Billing and coding information for Jemperli can be found through GSK. Visit Here →

Are there any available Jemperli patient assistance programs?

Jemperli patient assistance information can be found through GSK. Visit Here →

Where can I find Jemperli prescribing information?

Jemperli prescribing information can be found at the link below: Visit Here →

Where can I find Jemperli side effect information?

Information regarding Jemperli's side effects can be found at MedlinePlus Visit Here →

Does billing Jemperli require JZ/JW wastage modifiers?

CMS has identified Jemperli(J9272) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.